AG

Aditya Gupta

Active Director Director DIN 00694184
DIN 00694184 First appointment Jan 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jan 2005
Shareholding value •••• Premium profile

About Aditya Gupta

Data last updated:

Aditya Gupta is a Director at Nixi Laboratories Private Limited (since 2021), Director at Enrobage India Private Limited (since 2020) and Director at Transglobal Odyssey Private Limited (since 2022). The companies operate in Pharma and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹89.49 Cr; the largest is Nixi Laboratories Private Limited at ₹80.22 Cr (FY 2025). Earlier, Aditya Gupta was a Director at P R Pharma Source Private Limited (2013–2015) and Director at M M D Healthcare Limited (from 2005).

DIN 00694184
Primary Designation Director
Industry Pharma
First Appointment 08 Jan 2005
Oldest Company Age 30 yrs
Largest company Nixi Laboratories Private Limited · ₹80.22 Cr (FY 2025)
Combined revenue ₹89.49 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nixi Laboratories Private Limited U24100HP2016PTC001167
Director01 Mar 20212016₹80.22 Cr (FY 2025)Active
Enrobage India Private Limited U24296HR2020PTC089434
Director18 Sep 20202020₹7.03 Cr (FY 2023)Active
Transglobal Odyssey Private Limited U46909DL2022PTC392157
Director09 May 20222022₹2.25 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
P R Pharma Source Private Limited U52311MH2007PTC171721
Director01 Jan 20132007₹56.27 Cr (FY 2025)Active
M M D Healthcare Limited U65921CH1996PLC017595
Director08 Jan 20051996Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
M M D Healthcare Limited
Nixi Laboratories Private Limited
Enrobage India Private Limited
Transglobal Odyssey Private Limited
Premium access

Shareholding and investment profile for Aditya Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditya Gupta

Aditya Gupta currently holds 3 directorships: Nixi Laboratories Private Limited (Director, since 01 Mar 2021, revenue ₹80.22 Cr (FY 2025)); Enrobage India Private Limited (Director, since 18 Sep 2020, revenue ₹7.03 Cr (FY 2023)); Transglobal Odyssey Private Limited (Director, since 09 May 2022, revenue ₹2.25 Cr (FY 2025)).

Aditya Gupta was first appointed on 08 Jan 2005 as Director at M M D Healthcare Limited. The most recent appointment on record is 09 May 2022 at Transglobal Odyssey Private Limited.

The 3 current companies of Aditya Gupta that report revenue have a combined latest revenue of ₹89.49 Cr: Nixi Laboratories Private Limited ₹80.22 Cr (FY 2025); Enrobage India Private Limited ₹7.03 Cr (FY 2023); Transglobal Odyssey Private Limited ₹2.25 Cr (FY 2025).

Aditya Gupta held 2 earlier board appointments: P R Pharma Source Private Limited (Director, 01 Jan 2013 to 20 Jan 2015); M M D Healthcare Limited (Director, from 08 Jan 2005).

The current boards of Aditya Gupta's companies include Gurudev Singh Raina (Nixi Laboratories Private Limited), Harmanpreet Singh (Nixi Laboratories Private Limited), Paresh Shantilal Bagadia (Nixi Laboratories Private Limited), Nand Kishore Joshi (Enrobage India Private Limited), Nitin Bansal (Enrobage India Private Limited), Yug Garg (Enrobage India Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available